OBJECTIVE: The aim of this study was to inform best evidence-based practice by collating and disseminating the experiences of members of the International Pediatric Peritoneal Dialysis Network with children having concurrent ventriculoperitoneal shunts (VPS) and peritoneal dialysis catheters (PDC). METHODS: An online questionnaire was created and distributed to all 135 centers participating in the International Pediatric Peritoneal Dialysis Network; the overall response rate was 56 %. RESULTS: A total of 18 patients with a concurrent VPS and PDC were reported. The children were 0-12 (mean 6.8) years old at the time of placement of the second indwelling device (PDC or VPS). In 15 cases, the PDC was inserted post-VPS. On average, the two catheters were present concurrently for 23 (range 1-60) months. There were 20 episodes of peritonitis observed in 11 of the 18 patients during a period of 392 months at risk, which is a peritonitis rate of 1/19.6 months. Only one patient developed both a VPS infection and an episode of peritonitis, and these events were temporally unrelated. No episodes of an ascending shunt infection or meningitis occurred in association with any episode of peritonitis, and no other complications of catheter dysfunction were described. CONCLUSIONS: The rate of peritonitis, the absence of any documented ascending or descending infections and the lack of catheter dysfunction during the period of observation suggests that the presence of, or need for, a VPS should not preclude PD as a safe option for children requiring renal replacement therapy.
OBJECTIVE: The aim of this study was to inform best evidence-based practice by collating and disseminating the experiences of members of the International Pediatric Peritoneal Dialysis Network with children having concurrent ventriculoperitoneal shunts (VPS) and peritoneal dialysis catheters (PDC). METHODS: An online questionnaire was created and distributed to all 135 centers participating in the International Pediatric Peritoneal Dialysis Network; the overall response rate was 56 %. RESULTS: A total of 18 patients with a concurrent VPS and PDC were reported. The children were 0-12 (mean 6.8) years old at the time of placement of the second indwelling device (PDC or VPS). In 15 cases, the PDC was inserted post-VPS. On average, the two catheters were present concurrently for 23 (range 1-60) months. There were 20 episodes of peritonitis observed in 11 of the 18 patients during a period of 392 months at risk, which is a peritonitis rate of 1/19.6 months. Only one patient developed both a VPS infection and an episode of peritonitis, and these events were temporally unrelated. No episodes of an ascending shunt infection or meningitis occurred in association with any episode of peritonitis, and no other complications of catheter dysfunction were described. CONCLUSIONS: The rate of peritonitis, the absence of any documented ascending or descending infections and the lack of catheter dysfunction during the period of observation suggests that the presence of, or need for, a VPS should not preclude PD as a safe option for children requiring renal replacement therapy.
Authors: Robert A Avery; Samir S Shah; Daniel J Licht; Jeffrey A Seiden; Jimmy W Huh; Jan Boswinkel; Michael D Ruppe; Amber Chew; Rakesh D Mistry; Grant T Liu Journal: N Engl J Med Date: 2010-08-26 Impact factor: 91.245
Authors: Thomas C Manning; Anthony M Avellino; Jordan Symons; Jeffery Ojemann; Richard G Ellenbogen Journal: Pediatr Neurosurg Date: 2007-12-14 Impact factor: 1.162
Authors: Stephen Haggerty; Scott Roth; Danielle Walsh; Dimitrios Stefanidis; Raymond Price; Robert D Fanelli; Todd Penner; William Richardson Journal: Surg Endosc Date: 2014-10-08 Impact factor: 4.584
Authors: Eugene Y H Chan; Dagmara Borzych-Duzalka; Caner Alparslan; Elizabeth Harvey; Reyner Loza Munarriz; Dariusz Runowski; Enrico Vidal; Paula A Coccia; Augustina Jankauskiene; Iliana Principi; Erkin Serdaroglu; Maria Szczepanska; Yincent Tse; Aida Vazquez; Donald J Weaver; Franz Schaefer; Bradley A Warady Journal: Pediatr Nephrol Date: 2019-10-30 Impact factor: 3.714